JAZZ News and Press, Jazz Pharmaceuticals plc From 04/23/24

Originally published by Jazz Pharmaceuticals NORTHAMPTON, MA / ACCESSWIRE / April 23, 2024 / Purple Day spotlights epilepsy and the challenges that people face when living with the condition. Jazz wants the epilepsy community know that they are not alone and showed support by sporting pu...

2024-04-18 13:26:38 ET Summary Jazz Pharmaceuticals plc has a neuroscience franchise that is led by Xywav, which has replaced Xyrem as the top treatment for narcolepsy. The company's narcolepsy franchise is facing competition from Avadel Pharmaceuticals' Lumryz, but Jazz is defend...

Jazz Pharmaceuticals to Report 2024 First Quarter Financial Results on May 1, 2024 PR Newswire DUBLIN , April 17, 2024 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2024 first quarter financial results on Wednes...

2024-04-17 07:04:07 ET More on Eli Lilly Eli Lilly: Three Threats To Its Huge Rally Why Eli Lilly And Rival Novo Nordisk Won't Be Troubled By Viking's Latest Weight Loss Data Eli Lilly: Diabetes And Weight Management Treatments Are The Winning Tickets GLP-1s ...

A look at the top 10 most actives in the United States Jaguar Health Inc. (JAGX) rose 50.1% to $0.1783 on volume of 599,794,977 shares WiSA Technologies Inc. (WISA) rose 248.6% to $6.1 on volume of 197,912,579 shares PROSHARES TRUST (SQQQ) rose 0.0% to $11.44 on volume of 182,001,060 shar...

2024-04-15 04:31:00 ET Summary Jazz Pharmaceuticals is rated as a "Buy" due to its current financial health, multiple near-term catalysts, and projected growth for 2024 and 2025. The company's successful commercial products include Xywav, Epidiolex, and Rylaze, which have shown in...

A look at the top 10 most actives in the United States Trio Petroleum Corp. (TPET) rose 123.3% to $0.516 on volume of 328,807,701 shares PROSHARES TRUST (SQQQ) rose 4.7% to $10.89 on volume of 174,876,648 shares Nikola Corporation (NKLA) fell 2.3% to $0.7003 on volume of 136,204,677 share...

Jazz Pharmaceuticals to Showcase Expansive Neuroscience Portfolio at American Academy of Neurology Annual Meeting PR Newswire Two oral presentations share results of real-world impact of idiopathic hypersomnia and long-term effectiveness of Epidiolex® (cannabidiol) in tre...

Jazz Pharmaceuticals Completes Zanidatamab Biologics License Application for Previously Treated HER2-Positive Metastatic Biliary Tract Cancer PR Newswire Submission based on data from Phase 2b HERIZON-BTC-01 trial, which met its primary endpoint in patients receiving zanid...

Oncology is a tricky sector in which to innovate, but we can start by optimizing existing combination approaches NORTHAMPTON, MA / ACCESSWIRE / March 28, 2024 / Jazz Pharmaceuticals By Liz Henderson Liz Henderson, Sr. Vice President Technical Operations at Jazz Pharmaceuticals discusses...